What Are the Challenges in Nanotechnology-Based Immunosuppressive Therapies?
Despite the promising potential, several challenges need to be addressed:
- Biocompatibility: Ensuring that nanoparticles do not elicit an immune response themselves. - Scaling Up: Manufacturing nanoparticles consistently and cost-effectively on a large scale. - Regulatory Approvals: Navigating complex regulatory pathways for clinical approval. - Long-Term Effects: Understanding the long-term impact of nanoparticles in the body.
